Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine to mitigate propofol-induced hemodynamic inhibition in elderly surgical patients
ChiCTR2400083820Phase 4Recruiting
- Sponsor
- Shidong Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Cardiovascular collapse (2 arms), sponsored by Shidong Hospital. Primary endpoint: Blood pressure. Started May 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
Cardiovascular collapse
Beyond the preview
Go deeper on ChiCTR2400083820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083820.